Prescribing shift for Pfizer’s Paxlovid expands access but draws questions
Pharmaceutical Technology
JULY 20, 2022
However, the American Medical Association (AMA) released a statement warning that while most patients benefit from Paxlovid, it is not for everyone. Ganio says that, ideally, once an individual receives a positive Covid-19 result, they should call their pharmacy or communicate through a drive-through facility to minimize the risk of exposure.
Let's personalize your content